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Reversibility of experimental secondary hyperparathyroidism. Chronic
uremia is associated with secondary hyperparathyroidism (HPT). The
purpose of the present investigation was to study the reversibility of
secondary HPT after reversal of uremia by an isogenic kidney transplan-
tation in the rat. Secondary HPT was induced in two models: Model A
comprised 5/6 nephrectomized rats kept on a standard diet (N = 12; PTH
210 43 pg/mI; plasma urea 24 2 mmol/liter; and normal control rats,
N = 12; PTH 45 5 pg/mI; plasma urea 6 0.2 mmol/liter); and Model
B comprised 5/6 nephrectomized rats kept on a high phosphorus diet (N
12; PTH 769 157 pg/mI; plasma urea 18 2 mmol/liter). The
parathyroid function was examined by measuring the secretory response of
PTH to an acute induction of hypo- and hypercalcemia. Acute hypocal-
cemia in the hyperphosphatemic uremic rats did not significantly increase
serum PTH levels (N = 6, Ca2 —0.56 mmol/liter; maximal PTH 1045
164 pg/ml; basal PTH 690 134 pg/ml; NS). During hypercalcemia the
PTH levels were significantly higher than in the normal controls (N = 6;
minimal PTH 24 5 pg/mI vs. normal controls 5 0.2 pg/mI, P < 0.05).
After 20 weeks of uremia, the uremia was reversed by the isogenic kidney
transplantation. One week after reversal of the uremia the PTH levels
became normal in both models A and B (28 6 and 63 16 pg/ml,
respectively) and the kidney transplanted rats from model B had a normal
secretory response of PTH to both hypo- and hypercalcemia. To study
whether both parathyroid cell hypertrophy and hyperplasia could be
down-regulated, 8 uremic glands (N = 9) or 20 normal glands (N = 6)
were implanted into one normal rat. Within two weeks the rats regained
normocalcemia and PTH levels remained normal from the third day after
the increase of glandular mass. The 20 gland rats all had normal PTH
suppressibility in response to calcium (minimal PTH 5 0.3 pg/mI). In
conclusion, experimental severe secondary hyperparathyroidism is revers-
ible very quickly after the reversal of uremia. Hyperphosphatemia in
uremia is important for the non-suppressibility of the parathyroid glands
to calcium. In non-uremic rats even severe parathyroid hyperplasia can be
controlled, resulting in normal plasma PTH and Ca2 levels and in a
normal response to hypercalcemia. Thus, the minimal PTH secretion
obtained during the induction of hypercalcemia is not an expression of the
parathyroid mass.
Secondary hyperparathyroidism (HPT) is a serious condition
that develops early in renal insufficiency and it may affect the
function of several organs. The stimuli for the development of
secondary HPT relevant to renal failure are hypocalcemia, hyper-
phosphatemia, and low 1,25(OH)2D3. Hypocalcemia increases the
PTH gene expression per cell, increases the secretion of mature
PTH from the parathyroid cells, and increases the number of
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parathyroid cells [1—5]. Besides reducing the plasma Ca2 con-
centration, hyperphosphatemia has a calcium independent effect
on the regulation of PTH secretion. This has been demonstrated
recently in vivo in rats [6] and in in vitro models in rat and bovine
parathyroid glands [7—9]. Calcitriol [1,25(OH)2D3] is an important
regulator of the PTH gene and may play a specific role in the
control of the glandular mass [10—111. The levels of calcitriol in
mild and moderate uremia are maintained in the normal range at
the expense of elevated PTH; however, the parathyroid cells
during uremia may have fewer vitamin D receptors and an
impaired affinity of vitamin D to its receptor, resulting in a
reduced activity of calcitriol [12, 131.
In the management of secondary HPT, it is important to
prevent the development of non-suppressible and non-reversible
changes in the parathyroid glands. Therefore, the aim of the
present investigation was to study the reversibility of secondary
HPT after reversal of uremia by an experimental isogenic kidney
transplantation. Secondary HPT was induced in two rat models.
Model A rats were stimulated to develop moderate secondary
HPT by long-term uremia, and model B rats had severe secondary
HPT induced by long-term uremia together with a high phosphate
diet. Since it is still uncertain whether only hypertrophy or both
hypertrophy and hyperplasia of the parathyroid glands are in-
duced in experimental models of secondary HPT [14, 15], this
study included models of hyperplasia in which 8 glands from
uremic rats or 20 normal parathyroid glands were implanted into
one normal rat after the parathyroidectomy (PTX) of its own
glands.
METHODS
Animals
Inbred male DA rats, weighing 250 g at the start of the study
were used. The experimental studies on the rats were performed
in accordance with the NIH Guide for Care and Use of Labora-
tory animals and was approved by our institution.
Chronic renal failure
Chronic renal failure (CRF) was induced by a one step 5/6
nephrectomy procedure. The duration of uremia was 20 weeks.
Only rats with plasma urea > 15 mmol/Iiter and plasma creati-
nine > 100 mol/liter (measured 3 weeks after nephrectomy)
were included in the study.
Parathyroidectomy
Parathyroidectomy (PTX) was performed as a selective removal
of the two parathyroid glands, and was confirmed by a drop in
plasma PTH to undetectable levels within 60 minutes.
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Induction of secondary hyperparathyroidism
Model A. CRF rats were kept for 20 weeks on a standard diet
containing 0.9% calcium (Ca), 0.7% phosphorus (P), and 1000 IU
vitamin D/kg.
Model B. CRF-rats were kept for 20 weeks on a high phospho-
rus diet containing 0.9% Ca, 1,5% phosphorus, and 1000 IU
vitamin D/kg.
Reversal of uremia and secondary hyperparathyroidism by an
isogenic kidney transplantation
After 20 weeks of chronic uremia, the uremia was reversed by
an isogenic kidney transplantation. The kidney was transplanted
into the left orthopic side with end-to-end anastomoses of the
blood vessels and of the ureter. We have described this technique
in detail elsewhere [16]. The advantage of this renal transplant
model is that there is no rejection of the transplant and no need
to use imunosuppressive or antihypertensive treatment.
Twelve rats from model A and 12 rats from model B had a
successful kidney transplantation, and afterwards the rats from
both models were kept on a standard diet. PTH, kidney function,
plasma calcium, and plasma phosphorus were monitored weekly
during the first five weeks and again after another 10 weeks.
Secretory parathyroid hormone response to acute induction of
hypocalcemia
The parathyroid function was examined by the secretory re-
sponse of PTH to hypocalcemia in six rats with severe HPT after
20 weeks of uremia (model B) and in six rats (from model B) three
weeks after the reversal of uremia by the kidney transplantation.
For comparison, similar studies were performed in six rats with
normal kidney function. Hypocalcemia was induced by an infusion
of 30 mtvt EGTA, 3 ml/hr via a catheter inserted in a femoral vein.
Samples for determination of plasma Ca2 and plasma PTH were
taken at 0, 5, 10, 20, 30, 40, and 50 minutes from a corresponding
catheter in the femoral artery. The sample volume of 1 ml was
replaced by 1 ml of saline, resulting in the study rats having the
same weight both before and after the experiments.
Secretory parathyroid hormone response to acute induction of
hypercalcemia
The secretory response to hypercalcemia was examined in six
rats with severe HPT after 20 weeks of uremia (model B), in six
rats with moderate HPT after 20 weeks of uremia (model A), in
six rats (from model B) three weeks after reversal of uremia by the
kidney transplantation, and in six normal control rats. Hypercal-
cemia was induced by an infusion of 25 m Ca (Sandoz Pharma-
ceuticals) at 3 mI/hr via a catheter inserted in the femoral vein.
Samples for determination of plasma Ca2 and plasma PTH were
taken at 0, 5, 10, 20, 30, 40, and 50 minutes from a corresponding
catheter in the femoral artery and the blood volume loss was
replaced by saline.
Re-induction of hyperparathyroidism
We wanted to know if the rats, which previously had been
uremic and had severe secondary HPT after reversal of the
uremia and after normalization of the circulating PTH levels, still
retained the capacity for an abnormal response to stimuli that are
involved in the development of secondary HPT (that is, hyper-
phosphatemia and hypocalcemia). Therefore, five kidney trans-
planted rats (from model B) five weeks after the transplantation,
and nine normal control rats of the same age were kept on special
diets.
For the first two weeks the rats were placed on a standard
calcium, high phosphorus diet (0.9% Ca, 1.5% phosphorus, and
1000 IU vitamin D/kg) in order to check the phosphorus handling
of the transplanted kidney graft. During the following four weeks
the rats injestcd a high phosphorus/low calcium/vitamin D-defi-
cient diet (1.2% phosphorus, 0.02% Ca, no vitamin D) in order to
induce chronic hypocalcemia and hyperphosphatemia. Plasma
PTH, kidney function, plasma calcium and plasma phosphorus
levels were monitored at the end of each diet period.
To ensure that the PTH response in kidney transplanted rats
during the high P/low Ca diet treatment was not influenced by a
reduced kidney mass (kidney transplanted rats had only one
kidney), a model of rats with normal kidney mass (2 kidneys) and
previously "uremic" parathyroid glands was studied. Therefore, a
group of nine normal rats underwent acute PTX and each rat then
received an implantation of two parathyroid glands from chronic
uremic HPT rats (from model B). Plasma Ca2 and plasma PTH
values were followed for five weeks and then the rats were
challenged by the high P/low Ca/no vitamin D diet for another
four weeks.
Models of parathyroid hyperplasia
A model of 8 uremic glands. In order to examine whether not
only hyperparathyroidism due to parathyroid hypertrophy, but
also hyperparathyroidism due to parathyroid hyperplasia could be
down-regulated in non-uremic conditions, 8 uremic glands from
hyperparathyroid CRF rats (model A) were implanted into the
neck muscles of each of 9 recipient normal rats 60 minutes after
the PTX of their own parathyroid glands. The isogenic implanta-
tion of the glands was performed by an immediate transposition
from the donor to recipient rats. Plasma Ca2 and plasma PTH
values were monitored for 20 days after the parathyroid gland
implantations.
A model of 20 normal glands. This part of the study was
performed to examine whether an increased parathyroid mass by
itself in the normal non-uremic rat would result in an increase of
PTH and Ca2 levels, and in an abnormal response to hypo- or
hypercalcemia. Therefore, a model of pure hyperplasia was
introduced by an isogenic implantation of 20 normal parathyroid
glands into one rat (N = 6) after PTX of its own glands. Plasma
Ca2 and PTH levels were monitored for six weeks. Subsequently
the parathyroid function was examined by the secretory responses
to acute induction of hypo- and hypercalcemia using the methods
described above.
Control models. In the control model 1, five normal rats
underwent acute PTX and then received an isogenic implantation
of two normal parathyroid glands in order to determine the
viability of the glands and to check whether the operative proce-
dure by itself might result in changes in the calcium homeostasis.
In control model 2, 8 normal parathyroid glands were im-
planted into the neck of each of 5 uremic (model B) rats after
PTX of their own glands in order to determine whether the rats
with implanted glands would develop severe hyperparathyroidism.
The rats were maintained on a high phosphorus diet and the
development of hyperparathyroidism was monitored by daily
sampling for plasma PTH and plasma Ca2 .
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Table 1. Kidney function in uremia and after isogenic kidney transplantation
Experimental Plasma urea
groups, N = 12 mmoi/i
Normal 6 0.2
controls
20 weeks of CRF
Model A
1 week after RIT
Model A
15 weeks after RIT
Model A
20 weeks of CRF
Model B
1 week after RIT
Model B
15 weeks after RIT
Model B
Plasma calcium Plasma magnesium
mmoi/iiter
2.48 0.03
Plasma phosphorus Plasma 1,25(OH)2D3
__________________
pg/mi
1.45 0.08 77 16
1.48 0.06 60 3
1.50 0.10
1.49±0.08 59±3
3.0 0.30 78 14
1.49 0.11
1.39 0.01 67 6
P < 0.001 versus levels of controls and after renal isogenic transplantation (RIT).
Plasma measurements
Plasma PTH was measured by a rat PTH (IRMA) assay from
the Nicholls Institute (San Francisco, CA, USA). The intra-assay
coefficient of variance in our laboratoiy was 4% at all levels, and
the inter-assay coefficient of variance was 35% for a PTH level of
7 pg/mi, 5% for PTH of 40 pg/mI, and 5% for PTH of 260 pg/mi.
No cross-reactivity with C-terminal PTH fragments was found in
our laboratory. Vitamin D [1,25(OH)2D3] was measured by a
competitive RIA assay, and was extracted from plasma as de-
scribed by Reinhard et al [17]. Calf thymus was used as the source
of receptor protein. The intra-assay coefficient of variation was
4% and the inter-assay coefficient of variation was 14% for a
1,25(OH)2D3 level of 35 pg/mI. Plasma creatinine, urea, phospho-
rus, magnesium and total Ca were measured by an ETACHEM
250 Analyzer (Kodak). Plasma Ca2 at an actual pH was mea-
sured by a calcium selective electrode (Radiometer, Copenhagen,
DK).
Statistics
The results are expressed as mean SEM. The Mann-Whitney
test was used for the comparison between groups, and P < 0.05
was considered significant.
RESULTS
Kidney function, calcium, phosphorus, magnesium and vitamin
D in rats with uremia and after an isogenic kidney transplantation
are listed in Table 1.
Model A (standard diet). Rats that had a 5/6 nephrectomy and
injested a standard diet had a stable uremia for 20 weeks. Plasma
urea and plasma creatinine levels were significantly increased
(P < 0.001). Plasma calcium and plasma phosphorus values were
normal in this model, as was plasma J,25(OH)2D3. Plasma
magnesium was significantly increased (P < 0.001). One week
after kidney transplantation the kidney function was normalized,
plasma calcium and plasma phosphorus levels remained normal,
and plasma magnesium was normalized. Vitamin D levels mea-
sured 15 weeks after kidney transplantation were still normal.
Model B (high phosphorus diet). The kidney function in Model
B animals was identical to that of model A. The levels of plasma
calcium and plasma phosphorus were, however, severely dis-
turbed: plasma calcium levels were significantly decreased (P <
0.001), while plasma phosphorus levels were significantly (P <
0.001) increased after 20 weeks of uremia. Plasma 1,25(OH)2D3
values were normal after 20 weeks of uremia. One week after the
reversal of uremia, the kidney function, plasma calcium and
plasma phosphorus levels were normalized. Plasma 1,25(OH)2D3
was normal as measured 15 weeks after the kidney transplanta-
tion.
Plasma parathyroid hormone during uremia and after kidney
transplantation
In model A of secondary HPT, plasma PTH rose to four times
the upper normal level. In model B the rats developed severe
secondary HPT, as plasma PTH rose to 20 times the upper normal
level (Fig. 1). One week after the reversal of uremia in both
models A and B, the circulating levels of PTH were normal and
remained normal for the following 15 weeks.
Table 2 contains three examples of rats from model B with
extremely high PTH levels.
Secretory parathyroid hormone response to acute induction of
hypocalcemia
After 20 weeks of uremia in rats on a high phosphorus diet the
dynamics of the secretory PTH response to hypocalcemia was
severely disturbed (Fig. 2). The uremic rats did not respond with
an increase in the PTH secretion. Thus, the maximal PTH level of
1045 164 pg/mI obtained during a reduction of plasma Ca2 (
Ca2
—0.56 mmol/liter, P < 0.0001) was not significantly different
from the basal level of PTH of 690 134 pg/ml (Fig, 2A). When
studied three weeks after transplantation, the kidney transplanted
rats not only had a restored normal basal circulating PTH, but
also performed with a normal secretory response to hypocalcemia.
Thus, the maximal PTH (274 34 pg/mI) was 8 times that of basal
PTH (32 11 pg/ml), similar to that of normal rats (maximal
Plasma creatinine
pmoi/i
24 2
7 0.4
6 0.3
18 2
8 0.4
6 0.2
60 2
185 18
79 2
72 2
127 10
63 4
47 2
2.50 0.03
2.57 0.04
2.48 0.04
1.96 0.09
2.49 0.01
2.52 0.02
0.93 0.02
1.35 0.04
0.93 0.03
0.90 0.02
1.08 0.15
1.01 0.04
0.90 0.01
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_________
Time, weeks
Fig. 1. Kidney function and basal PTH levels before induction of uremia
by 5/6 nephrectomy (PNX), during uremia, and after reversal of uremia by
an isogenic kidney transplantation (JUT). The lines (—) depict the
kidney function expressed as plasma-urea, the bars (LI) depict basal PTH
levels in (A) a model of moderate secondary HPT in uremic rats kept on
a standard diet, and in (B) a model of severe secondary HPT in uremic rats
kept on a high P diet. N = 12; data are mean SEM.
PTH 200 17 pg/mI and basal PTH 44 10 pg/mI). The plasma
Ca2 was reduced by the same rate of EGTA infusions in all
experimental groups. However, the rates obtained for lowering
the Ca2 (Fig. 2B) were different between the three experimental
groups. Thus, the initial fall in plasma Ca2 ( Ca2 reduction
after 5 mm) was significantly faster (P < 0.05) in the kidney
transplanted than in the uremic or normal rats. Despite this faster
rate of Ca2 lowering, the kidney transplanted rats had lower
PTH secretion than uremic rats. During the following 40 minutes
of EGTA infusion the uremic and kidney transplanted rats
decreased their serum calcium at a similar rate.
Thus, during hypocalcemia, CRF rats had significantly higher
levels of PTH (P < 0.001), than kidney transplanted and normal
rats (Fig. 2A). At three weeks after renal transplantation, acute
hypocalcemia no longer increased serum PTH levels to those
reached in the uremic rats made hypocalcemic.
Secretory parathyroid hormone response to acute induction of
hypercalcemia
The suppressibility of the PTH secretion by calcium was
disturbed in the hyperphosphatemic uremic rats (model B; Fig. 3).
Plasma
urea
Plasma Plasma
calcium phosphorus Plasma PTH
pg/mimmol/liter
Rat no. 434
Day of RIT 17 1.62 3.47 720
I week after RIT 7 2.49 1.08 10
2 weeks after RIT 7 2.57 1.51 14
Rat no. 421
Day of RIT 29 1.60 4.03 1020
1 week after RIT 9 2.52 2.06 150
2 weeks after RIT 6 2.69 1.79 60
Rat no. 456
Day of RIT 20 1.80 4.08 1720
1 week after RIT 6 2.49 1.54 85
2 weeks after RIT 6 2.36 1.50 34
Thus, the minimal secretion of PTH obtained by an infusion of
calcium was significantly elevated in the hyperphosphatemic ure-
mic rats (minimal PTH, 24 5 pg/ml, P < 0.05, vs. normal and
model A rats), while in the normophosphatemic uremic rats PTH
secretion was completely suppressed, as in the normal control rats
(minimal PTH, 7 0.8 and 5 0.2 pg/mI, respectively). After the
reversal of uremia by the isogenic kidney transplantation in rats
from model B, these rats had completely restored, normal PTH
suppressibility (minimal PTH, 4 0.3 pg/ml).
Re-induction of hyperparathyroidism
After two weeks on the normal Ca/high P diet the kidney
transplanted and the normal control rats had similar plasma
phosphorus levels (1.74 0.04 mmol/liter and 1.60 0.06
mmol/liter, respectively, not significantly different from that of
control rats on the standard diet), indicating that the kidney
transplanted rats had regained a normal renal ability to handle
phosphorus.
Then for the subsequent four weeks, hyperphosphatemia and
hypocalcemia were induced by feeding the animals a low Ca/high
P/vitamin D-deficient diet. The kidney transplanted, previously
uremic rats and the normal control rats all achieved the same
degree of significant hyperphosphatemia (plasma phosphorus,
2.06 0.2 mmol/liter and 2.28 0.2 mmol/liter, vs. normal
control rats on a standard diet 1.50 0.1 mmol/liter, P < 0.05)
and similar degrees of significant hypocalcemia (plasma total Ca,
2.27 0.04 mmol/Iiter and 2.22 0.04 mmol/liter vs. normal
control rats on a standard diet 2.47 0.02 mmol/liter, P < 0.05).
Re-induction of thcse chronic stimuli for the development of HPT
resulted in a re-induction of severe hyperparathyroidism to the
same extent in both groups of rats (Fig. 4). All rats maintained
normal kidney function during the different dietary regimens.
The normal rats with normal kidney mass and two "uremic"
implanted parathyroid glands (from model B) regained normal
levels of Ca2 on the third day after PTX and implantation, and
then developed a short period of hypercalcemia (for 3 days). After
that episode, normocalcemia was maintained for the following five
weeks. PTH levels were maintained within the normal range
during the complete period of five weeks (Fig. 5). When placed on
the high P/low Ca/vitamin D-deficient diet for four weeks, these
A Table 2. Three examples of rats with extremely high PTH levels (from
model B: 20 weeks of uremia and high P diet) showing reversibility of
secondary HPT after reversal of uremia by renal isogenic
transplantation (RIT)
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Fig. 2. (A) Ca2-PTH relationship during an acute induction of hypocal-
cemia in (--S) uremic rats from model B (high P diet), in (-
- -) kidney
transplanted rats from model B three weeks after reversal of the uremia,
and in (—) normal control rats. The PTH secretory response of the uremic
rats was significantly higher (P < 0.001) than that of the kidney trans-
planted and of the normal control rats. (B) The rate of Ca reduction
during an acute induction of hypocalcemia. The initial rate of Ca2
reduction (at 5 mm) was significantly faster (P < 0.05) in kidney
transplanted than in uremic rats. N = 6; data are mean SaM,
rats developed the same increase in plasma PTH levels as that of
control rats and kidney transplanted rats (Fig. 4).
Ca2 and PTH in models of parathyroid hyperplasia
A model of eight uremic glands. Figure 6 shows the plasma Ca2
and plasma PTH levels in normal rats with eight isogenic uremic
glands implanted after PTX of their own glands. After a short
transient period with hypercalcemia all rats regained normal
levels of plasma Ca2. The PTH levels were normal from the third
day after implantation of the eight parathyroid glands and re-
mained normal for the observation period of 20 days.
A model of 20 normal glands. Figure 7 shows the plasma Ca2
and plasma PTH levels in normal rats with 20 isogenic normal
glands implanted after PTX of their own glands. A transient
period of hypercalcemia occurred initially after the increase of the
parathyroid mass, however, within two weeks the plasma calcium
returned to normal and remained normal for six weeks. PTH
levels were normal from the third day after implantation of the 20
Fig. 3. The Ca2-PTH relationship during an acute induction of hyper-
calcemia in (- - -) uremic hyperphosphatemic rats from model B, in
uremic normophosphatemic rats from model A, in (—-) kidney trans-
planted (previously uremic, hyperphosphatemic) rats, and in (—-) normal
control rats. The PTH secretion was suppressed to same extent in uremic
normophosphatemic rats, kidney transplanted rats and normal control
rats, while uremic hyperphosphatemic rats had a significantly higher (P <
0.05) PTH secretion at high Ca2. N = 6; data are mean SCM.
parathyroid glands in these animals (20 gland rats) and remained
normal for the six weeks of observation.
Subsequently, the parathyroid function of the 20 gland rats was
examined by an acute induction of hypo- and hypercalcemia.
Figure 8 shows the secretory PTH response to hypocalcemia. The
PTH levels obtained in the 20 gland rats were significantly higher
than those of normal rats (P < 0.05). However, despite the same
rate of EGTA infusion, the 20 gland rats responded initially with
a significantly faster (P < 0.05) rate of lowering of plasma Ca2.
PTH secretion has been shown to vary in response to the rate of
change in serum calcium [181, which may explain the increased
PTH secretion. Figure 9 shows the secretory PTH response to
hypercalcemia. The 20 gland rats had a normal PTH suppressibil-
ity to calcium infusion (minimal PTH, 5 0.3 pg/mI).
Control models. Figure 10 shows the plasma Ca2 and plasma
PTH levels in rats from the control model 1 in which two normal
parathyroid glands were implanted into normal rats after PTX. It
appears that both plasma Ca2 and plasma PTH were maintained
within normal ranges after the third day, and thus no hypercalce-
mia was observed in this control model in which the parathyroid
mass was not increased.
Figure 11 shows the plasma Ca2 and plasma PTH levels in rats
from control model 2, where 8 normal parathyroid glands were
implanted into uremic hyperparathyroid rats after the PTX of
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Fig. 4. PTH levels in normal control rats (N = 9), in kidney transplanted
rats (previously uremic rats from model B) (N = 5), and in rats with
normal kidney mass and two "uremic" implanted parathyroid glands
(from rats of model B; N = 9), all kept on the standard diet (Li) and later
on a special diet (•; low Ca/high P/no vitamin D) for re-induction of
secondary HPT. < 0.001; data are mean SEM.
Fig. 5. Plasma Ca2 (line) and plasma PTH level (bar) in normal rats
that underwent acute PTX and had two "uremic" glands implanted (from
rats of model B; N = 9). Day 0 depicts the plasma levels before PTX. After
five weeks the rats received a special diet (high P/low Ca/no vitamin D)
and four weeks later the rats developed significant HPT (P < 0.001). *p <
0.05 versus the level at day 0; data are mean SuM.
their own glands. In these rats with newly-implanted normal
glands, hyperparathyroidism quickly re-developed by the third day
(PTH, 117 15 pg/mI) and PTH levels increased progressively
during the observation time of 10 weeks, ending at the same level
as that of the start of the experiments (PTH, 750 211 pg/ml at
start and 772 250 pg/mi 10 weeks after implantation of the
normal glands). Initially plasma Ca2 decreased dramatically
(from 1.01 0.06 mmol/liter to 0.71 0.12 mmol/liter after two
days, P < 0.05) and then increased again in parallel to the
development of the hyperparathyroidism, ending at 0.95 0.13
mmol/liter on the seventh day of the experiment. Thus, the
viability of the implanted parathyroid glands was confirmed by the
rapid development of hyperparathyroidism in this control model.
40H
1LJ
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0
0 1 2 3 4 5 6 7 89 1011121314151617181920
Time, days
Fig. 6. Plasma Ca2 (A) and plasma PTH (B) levels in rats from a model
of parathyroid hyperplasia. Eight "uremic" isogenic glands were im-
planted into each normal rat, after PTX of their own glands. The values at
day 0 were obtained before PTX. *p < 0.05 versus the level at day 0. N =
9, mean SEM.
DISCUSSION
The results of the present study in rats have clearly shown that
experimental secondary HPT due to long-term uremia was revers-
ible very rapidly after reversal of the uremia, Even severe
secondary HPT due to long-term uremia associated with hypocal-
cemia and hyperphosphatemia was rapidly reversible. In both
models A and B the circulating PTH levels became normal as
early as within one week after normalization of the kidney
function, plasma calcium and plasma phosphorus levels. When
re-introducing factors that promoted the development of second-
ary HPT, these previously hyperparathyroid rats developed a
significant increase of their PTH levels, but so did the control rats
and the normal rats after the implantation of HPT glands. The
precise mechanism involved in the development of the uremic
secondary HPT has not yet been completely clarified, nor is the
mechanism behind this rapid reversal of the secondary HPT after
normalization of GFR completely understood.
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Fig. 7. Plasma Ca2 (A) and plasma PTH (B) levels in rats from a model
of parathyroid hyperplasia. Twenty normal isogenic glands were im-
planted into each normal rat, after PTX of their own glands. The values at
day 0 were obtained before PTX. *p < 0.05 versus the level at day 0. N =
6; data are mean SEM.
The major determinant of PTH biosynthesis and secretion is
the plasma level of ionized calcium. The parathyroid cell senses
the Ca2 levels in the extracellular fluid by a calcium sensing
receptor (CaR) [191, but as yet it is not known whether abnormal
regulation of the CaR can explain the secondary HPT. According
to recent reports the CaR's gene expression in the parathyroid
glands is unaffected in three different rat models of secondary
HPT, whether induced by CRF, by low dietary calcium [20] or by
vitamin D deficiency [21]. Even though it is still possible that the
functional properties of the CaR are affected by chronic uremia,
the question of the altered parathyroid sensitivity to calcium
remains controversial. An altered calcium set-point of the para-
thyroids in chronic uremia has been shown in vitro [22]. However,
the existing in vivo models that have been used to investigate this
relationship are inappropriate due to the complexity of the
Ca2-PTH relationship, for example, factors such as rate depen-
dency and ability of the parathyroids to sense the direction of
calcium changes [18, 23, 24]. Therefore, we did not determine the
Fig. 8. Secretory response of PTH to an acute induction of hypocalcemia
(A) and the rate of Ca2 reduction (B) in (—-) rats with 20 parathyroid
glands implanted compared to that of (- - -) normal control rats. *P <
0.05 versus value of control rats. N 6; data are mean SEM.
calcium set point. This is exemplified by Figure 2, which shows the
Ca2-PTH relationship during induction of hypocalcemia in CRF,
kidney transplanted and control rats. The set points (the Ca2
level at 50% suppression of the maximal PTH level) for the kidney
transplanted and the control rats are included in the data obtained
during the induction of hypocalcemia, while this is not the case for
the set point of the CRF rats. In these rats, 50% of maximal PTH
is below their basal PTH. This means that the set point for the
CRF rats is found on the curve created during the induction of
hypercalcemia. Therefore, these set point values cannot be com-
pared, as they originate from different directions of changes of
calcium. Furthermore, as shown in the present experiments,
increased parathyroid mass may influence the calcium homeosta-
sis. The same rate of EGTA infusion resulted in significantly
different rates of lowering of the plasma Ca2, which also might
influence the set point values. Thus, the present results confirm
our previous caution [25] about the interpretation of the Ca2-
PTH relationship, which must be viewed with great scepticism.
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Fig. 10. Control model 1. Plasma Ca2 (line) and plasma PTH (bar)
levels from normal rats, which after PTX had two normal parathyroid
glands implanted (N = 5). Day 0 depicts plasma levels before PTX.
Fig. 9. Secretory response of PTH to an acute induction of hypercalcemia
(A) and the rate of Ca2 increase (B) in (—-) rats with 20 parathyroid
glands implanted compared to that of (- - -) normal control rats. The
curves were not significantly different. N = 6; data are mean SEM.
Unfortunately, at the present time we do not have any useful
model for the evaluation of the calcium sensitivity of the parathy-
roid glands in vivo.
Another aspect on the understanding of the Ca2-PTH rela-
tionship, which is clarified in present investigation, is the inter-
pretation of the minimal PTH levels obtained during suppression
of the PTH secretion by calcium. The minimal PTH secretion seen
during the induction of hyperealcemia is considered by several
investigators to be an expression of the parathyroid mass [26—29].
No studies have proven this assumption, and it seems unlikely that
the non-suppressible PTH secretion is non-regulated, which
would be the obvious consequence, The present results, however,
clearly show that the PTH secretion can be completely suppressed
when hypercalcemia is induced in rats with an increased parathy-
roid mass, that is, in rats with the 20 parathyroid glands, in uremic
normophosphatemic rats and in kidney transplanted rats that
previously had severe HPT.
The explanation for the rapid normalization of the PTH levels
after kidney transplantation in the hypocalcemic rats from model
B could simply be due to suppression of PTH secretion secondary
to normalization of the plasma Ca2. This would be in accordance
with the hypothesis that PTH secretion in uremia already is
stimulated at the actual basal calcium level [29]. However, in the
kidney transplanted rats we were not able to restore the very high
PTH levels, seen in uremia, by an acute and considerable reduc-
tion of plasma Ca2t We therefore have to conclude that normal-
ization of circulating PTH after normalization of GFR is not a
simple function of calcium. Furthermore, HPT rats from model A
were not hypocalcemic before kidney transplantation, and despite
the fact that there were no changes in plasma Ca2 a rapid
normalization of PTH levels was seen after the reversal of uremia.
However, the present studies on hypocalcemia were acute, while
in uremia they were chronic. The changes in uremia reflect not
only PTH secretion, but also PTH mRNA levels. These acute
studies may, therefore, have been too short in duration to show an
effect on PTH gene expression, translation and then secretion.
The role of phosphorus in the regulation of parathyroid func-
tion is not yet completely solved. Recently, evidence has been
provided in favor of a direct calcium-independent role of phos-
phorus in the parathyroid cells [6—91. Even though in the present
study we are not able to dissociate the influence of phosphorus
from that of calcium, because the hyperphosphatemic model
(model B) was associated with hypocalcemia, it is interesting that
even severe hypercalcemia in the hyperphosphatemic rats was not
able to suppress PTH secretion to the same extent as that of
normal rats or that of uremic normophosphatemic rats, and that
this malfunction was normalized after the kidney transplantation.
These results underline the importance of phosphorus in the
abnormal suppressibility of PTH secretion by calcium.
Apoptosis would be an attractive explanation for the normal-
ization of PTH secretion after reversal of uremia, at least if
normalization was caused by a reduction of the glandular mass.
However, the parathyroids have an extremely low cell turnover
and, therefore, probably a poorly developed program for cell
deletion [30—32], just as it in general seems unlikely that normal-
ization of factors influencing parathyroid function could be a
stimulus for apoptosis. Treatment with vitamin D has been
suggested to induce apoptosis in the parathyroids [33]. The
detection of a possible overshot of vitamin D production after
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Fig. 11. Plasma Ca2 (A) and plasma PTH (B)levels in rats from control
model 2, testing the viability of the implanted parathyroid glands. Eight
normal parathyroid glands were implanted into each uremic hyperpara-
thyroid rat from model B, after PTX of their own glands. The values at day
0 were obtained before PTX. At the third day, the rats with newly-
implanted parathyroid glands re-developed significant hyperparathyroid-
ism (P < 0.05 vs. PTH levels of normal control rats). N = 6; data are
mean SCM.
kidney transplantation was not included in the present study.
However, it seems unlikely that such a phenomenon would result
in "pharmacological" levels of vitamin D.
It is not certain whether it is only hypertrophy and not
hyperplasia that is induced in experimental secondary HPT [14,
15]. The dynamics of the involution of hypertrophy might from a
speculative point of view include a transient period of up-
concentration of the calcium receptors on the surface of the
shrinking parathyroid cells, which could contribute to an eventual
transient increase of the calcium sensitivity and thus explain the
extremely rapid down-regulation of PTH secretion, as observed in
the present study.
Normalization of circulating PTH levels after reversal of uremia
does not exclude the persistence of an augmented parathyroid
mass. We examined whether it was possible to down-regulate
circulating PTH levels in the case of increased parathyroid mass.
It was very clearly shown that the rats maintained normal levels of
circulating PTH despite a significant increase of the parathyroid
mass tissue. In the model of hyperplasia a recipient normal rat
received 8 glands from CRF rats or 20 normal glands. In this
situation, not only the size of the parathyroid cells, but certainly
also the number of cells were increased, yet despite that, the PTH
levels remained normal.
A 20 gland model is a very old model introduced by Gittes and
Radde [34] at a time when measurements of rat PTH were not
available. This model has since been considered as a model of
hyperparathyroidism. The present results clearly show that the
circulating PTH levels are down-regulated in the 20 gland rats.
This might affect the previous interpretation of the early results of
Gittes and Radde.
The questions are: (1) does a switch-off mechanism exist in the
parathyroids, and (2) can the number of cells in an active
secretory state be down-regulated? Fitzpatrick and Leong [35]
suggested the existence of a calcium dependent recruitment of
secretory active parathyroid cells. In short-term in vitro experi-
ments performed on dispersed bovine parathyroid cells these
authors found that in high calcium conditions the number of cells
secreting PTH were lower than during low calcium conditions.
Furthermore, in another study from the same group [36], Ritchie
et al found that the parathyroid cells were cycling between an
active and a non-active secretory state. Regulation of the length of
this cycle could be the mechanism involved in the down-regulation
of PTH secretion in the case of increased parathyroid mass. Both
mechanisms could control to some extent the augmentation of the
glandular mass. Another possible explanation could be an in-
crease of the intracellular degradation of PTH inside the para-
thyroid cells. Cloutier et al [28] induced chronic HPT by giving a
high phosphorus/low calcium/low sodium/and vitamin D-deficient
diet to dogs. After normalization of the diet, the circulating intact
PTH levels returned to normal, but at the expense of an increased
secretion of C-terminal PTH fragments, suggesting a simulta-
neous up-regulation of the intracellular degradation of PTH.
Conclusion
Experimental moderate and severe secondary hyperparathy-
roidism is quickly reversible after the reversal of uremia. In
uremic hyperphosphatemic rats the PTH secretion could not be
completely suppressed by hypercalcemia, while in the uremic
normophosphatemic rats PTH secretion was completely suppre-
sed, as in normal rats, indicating the importance of phosphorus
for the suppressibility of PTH secretion by calcium. After reversal
of uremia by an isogenic kidney transplantation, the rats restored
normal secretory responses to acute induction of hypo- and
hypercalcemia. When chronic hypocalcemia and hyperphos-
phatemia were re-induced, these previously severe HPT rats
responded with a normal increase of the PTH levels and so did
normal rats with implantation of two "uremic" parathyroid glands.
This indicates that an increased parathyroid mass alone may not
result in an abnormal PTH response to stimulation by calcium
and/or phosphorus. Therefore, a further increased parathyroid
mass was introduced in normal rats by implantation of 20 glands.
These rats with 10 times increased parathyroid mass were, how-
ever, able to regain normocalcemia, normal PTH levels and
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normal suppressibility of PTH by calcium. Finally, the minimal
PTH secretion obtained during acute induction of hypercalcemia
is not an expression of the parathyroid mass.
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